1. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Fourth Edition. Washington, DC: American Psychiatric Association Press; 1994.
2. Cho SC, Shin YO. Prevalence of disruptive behavior disorders. Korean J Child Adolesc Psychiatry 1994;5:141–149.
3. Kim JY, Ahn DH, Shin YJ. An epidemiological study of attention deficit hyperactivity disorder and learning disabilities in a rural area. J Korean Neuropsychiatr Assoc 1999;38:788–793.
4. Faraone SV, Doyle AE. The nature and heritability of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2001;10:299316
5. DeLorey TM, Sahbaie P, Hashemi E, Homanics GE, Clark JD. “Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder”. Behav Brain Res 2008;187:207–220. PMID:
17983671.
6. McCauley JL, Olson LM, Delahanty R, Amin T, Nurmi EL, Organ EL, et al. A linkage disequilibrium map of the 1-Mb 15q12 GABA(A) receptor subunit cluster and association to autism. Am J Med Genet B Neuropsychiatr Genet 2004;131B:51–59. PMID:
15389768.
7. Samaco RC, Hogart A, LaSalle JM. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet 2005;14:483–492. PMID:
15615769.
8. Kolesnichenko LS, Kulinskiĭ VI, Gorina AS. Amino acids and their metabolites in blood and urine of children with minimal cerebral dysfunction. Vopr Med Khim 1999;45:58–64. PMID:
10205830.
9. Edden RA, Crocetti D, Zhu H, Gilbert DL, Mostofsky SH. Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2012;69:750–753. PMID:
22752239.
10. Miyazaki M, Ito H, Saijo T, Mori K, Kagami S, Kuroda Y. Favorable response of ADHD with giant SEP to extended-release valproate. Brain Dev 2006;28:470–472. PMID:
16554135.
11. Powell SG, Thomsen PH, Frydenberg M, Rasmussen H. Long-term treatment of ADHD with stimulants: a large observational study of reallife patients. J Atten Disord 2011;15:439–451. PMID:
20631198.
12. Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa JL. GABAA, NMDA and AMPA receptors: a developmentally regulated ‘ménage à trois’. Trends Neurosci 1997;20:523–529. PMID:
9364667.
13. Herlenius E, Lagercrantz H. Development of neurotransmitter systems during critical periods. Exp Neurol 2004;190(Suppl 1):S8–S21. PMID:
15498537.
14. Wang GX, Ma YH, Wang SF, Ren GF, Guo H. Association of dopaminergic/GABAergic genes with attention deficit hyperactivity disorder in children. Mol Med Rep 2012;6:1093–1098. PMID:
22895683.
15. Kim SA, Kim JH, Park M, Cho IH, Yoo HJ. Association of GABRB3 polymorphisms with autism spectrum disorders in Korean trios. Neuropsychobiology 2006;54:160–165. PMID:
17230033.
16. Kim YS, So YK, Noh JS, Koh YJ. The reliability and validity of Korean parent and teacher ADHD Rating Scale. J Korean Neuropsychiatr Assoc 2002;41:283–289.
17. Kovacs M. The Children's Depression Inventory: A Self-Rated Depression Scale for School-Aged Youngsters. Pittsburgh: University of Pittsburgh; 1983.
18. Cho SC, Choi JS. Development of Korean form of the state-trait anxiety inventory for children. J Seoul Psychiatry 1989;14:150–157.
19. Shin MS, Cho SC, Chun SY, Hong KM. A study of the development and standardization of ADHD diagnostic system. Korean J Child Adolesc Psychiatry 2000;11:91–99.